Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Amorepacific Discovers Skin Barrier Regulator EGR3 2021-05-13 10:31
Antengene Announces IND Approval in China for a Global Phase III Trial of Selinexor in Advanced or Recurrent Endometrial Cancer 2021-05-13 08:00
Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing 2021-05-12 18:12
Zymo Research Releases Open-Source Bioinformatics Pipeline for SARS-CoV-2 Variant Detection in Wastewater 2021-05-11 17:05
Hong Kong government endorses INDICAID(R) in visitation resumption arrangements 2021-05-11 08:00
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer 2021-05-11 04:01
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate 2021-05-10 21:55
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-05-10 20:00
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine 2021-05-10 20:00
Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology 2021-05-10 18:21
Bionomics BNC210 Expansion into Social Anxiety Disorder 2021-05-10 18:00
Hong Kong government endorses INDICAID(R) in visitation resumption arrangements 2021-05-10 11:30
New focus on male factors critical for success in human fertility treatment 2021-05-10 10:06
Hong Kong government endorses INDICAID(R) in visitation resumption arrangements 2021-05-10 10:00
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases 2021-05-10 08:13
Daewoong showed improved performance both sales and earnings in Q1 2021-05-07 21:00
Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA 2021-05-07 07:00
The world's first-in-class miRNA therapeutics to cure diabetes by pancreatic beta cell regeneration 2021-05-07 07:00
Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility 2021-05-06 21:53
HanAll Biopharma Reports First Quarter 2021 Financial Results 2021-05-06 21:00
1 245 246 247 248 249 451